REPORT ID 2316

United States Large Volume Parenteral (LVP) Market Report 2017

Publish Date
8-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the United States Large Volume Parenteral (LVP) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Large Volume Parenteral (LVP) in these regions, from 2012 to 2022 (forecast).

United States Large Volume Parenteral (LVP) market competition by top manufacturers/players, with Large Volume Parenteral (LVP) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Kelun Pharma
    Southwest Pharmaceutical Co. Ltd.
    China Otsuka Pharmaceutical
    Teva Pharmaceutical Industries Limited
    Cook Pharmica LLC
    Patheon Inc.
    BAG Healthcare
    Cook Pharmica LLC
    Beximco Pharma
    Baxter Healthcare Corporation

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Body Fluid Balance Injections
    Therapeutic Injections
    Nutritious Injections
    Peritoneal Dialysate
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    ?30 Years Old
    30 Years Old-60 Years Old
    ?60 Years Old

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Large Volume Parenteral (LVP) Market Report 2017
1 Large Volume Parenteral (LVP) Overview
    1.1 Product Overview and Scope of Large Volume Parenteral (LVP)
    1.2 Classification of Large Volume Parenteral (LVP) by Product Category
        1.2.1 United States Large Volume Parenteral (LVP) Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Large Volume Parenteral (LVP) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Body Fluid Balance Injections
        1.2.4 Therapeutic Injections
        1.2.5 Nutritious Injections
        1.2.6 Peritoneal Dialysate
    1.3 United States Large Volume Parenteral (LVP) Market by Application/End Users
        1.3.1 United States Large Volume Parenteral (LVP) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 ?30 Years Old
        1.3.3 30 Years Old-60 Years Old
        1.3.4 ?60 Years Old
    1.4 United States Large Volume Parenteral (LVP) Market by Region
        1.4.1 United States Large Volume Parenteral (LVP) Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Large Volume Parenteral (LVP) Status and Prospect (2012-2022)
        1.4.3 Southwest Large Volume Parenteral (LVP) Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Large Volume Parenteral (LVP) Status and Prospect (2012-2022)
        1.4.5 New England Large Volume Parenteral (LVP) Status and Prospect (2012-2022)
        1.4.6 The South Large Volume Parenteral (LVP) Status and Prospect (2012-2022)
        1.4.7 The Midwest Large Volume Parenteral (LVP) Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Large Volume Parenteral (LVP) (2012-2022)
        1.5.1 United States Large Volume Parenteral (LVP) Sales and Growth Rate (2012-2022)
        1.5.2 United States Large Volume Parenteral (LVP) Revenue and Growth Rate (2012-2022)

2 United States Large Volume Parenteral (LVP) Market Competition by Players/Suppliers
    2.1 United States Large Volume Parenteral (LVP) Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Large Volume Parenteral (LVP) Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Large Volume Parenteral (LVP) Average Price by Players/Suppliers (2012-2017)
    2.4 United States Large Volume Parenteral (LVP) Market Competitive Situation and Trends
        2.4.1 United States Large Volume Parenteral (LVP) Market Concentration Rate
        2.4.2 United States Large Volume Parenteral (LVP) Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Large Volume Parenteral (LVP) Manufacturing Base Distribution, Sales Area, Product Type

3 United States Large Volume Parenteral (LVP) Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Large Volume Parenteral (LVP) Sales and Market Share by Region (2012-2017)
    3.2 United States Large Volume Parenteral (LVP) Revenue and Market Share by Region (2012-2017)
    3.3 United States Large Volume Parenteral (LVP) Price by Region (2012-2017)

4 United States Large Volume Parenteral (LVP) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Large Volume Parenteral (LVP) Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Large Volume Parenteral (LVP) Revenue and Market Share by Type (2012-2017)
    4.3 United States Large Volume Parenteral (LVP) Price by Type (2012-2017)
    4.4 United States Large Volume Parenteral (LVP) Sales Growth Rate by Type (2012-2017)

5 United States Large Volume Parenteral (LVP) Sales (Volume) by Application (2012-2017)
    5.1 United States Large Volume Parenteral (LVP) Sales and Market Share by Application (2012-2017)
    5.2 United States Large Volume Parenteral (LVP) Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Large Volume Parenteral (LVP) Players/Suppliers Profiles and Sales Data
    6.1 Kelun Pharma
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Southwest Pharmaceutical Co. Ltd.
        6.2.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Southwest Pharmaceutical Co. Ltd. Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 China Otsuka Pharmaceutical
        6.3.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 China Otsuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Teva Pharmaceutical Industries Limited
        6.4.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Teva Pharmaceutical Industries Limited Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Cook Pharmica LLC
        6.5.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Cook Pharmica LLC Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Patheon Inc.
        6.6.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Patheon Inc. Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 BAG Healthcare
        6.7.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Cook Pharmica LLC
        6.8.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Cook Pharmica LLC Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Beximco Pharma
        6.9.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Baxter Healthcare Corporation
        6.10.2 Large Volume Parenteral (LVP) Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Baxter Healthcare Corporation Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Large Volume Parenteral (LVP) Manufacturing Cost Analysis
    7.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Large Volume Parenteral (LVP) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Large Volume Parenteral (LVP) Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Large Volume Parenteral (LVP) Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Large Volume Parenteral (LVP) Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Large Volume Parenteral (LVP) Sales Volume Forecast by Type (2017-2022)
    11.3 United States Large Volume Parenteral (LVP) Sales Volume Forecast by Application (2017-2022)
    11.4 United States Large Volume Parenteral (LVP) Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer